Trial Details
COMPLETEDBasic Information
| Clinical ID | c822 |
|---|---|
| Identifier | NCT05084261 |
| Trial Title | An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: BT051 200 mg|DRUG: BT051 800 mg|DRUG: BT051 3200 mg|DRUG: Matching Placebo |
Participant Information
| Sponsor | Adiso Therapeutics |
|---|---|
| City | Rialto |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2021-11-30 |
|---|---|
| Primary Completion Date | 2022-11-30 |
| Completion Date | 2022-11-30 |